• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Competing global statistics on prevalence of injecting drug use: why does it matter and what can be done?全球关于注射吸毒流行率的竞争统计数据:为什么这很重要,我们能做些什么?
Addiction. 2018 Oct;113(10):1768-1774. doi: 10.1111/add.14383. Epub 2018 Aug 9.
2
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.全球注射吸毒流行状况以及注射吸毒者的社会人口学特征和艾滋病毒、乙肝病毒及丙肝病毒流行状况:多阶段系统评价。
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23.
3
Estimating the number of people who inject drugs in Australia.估算澳大利亚注射毒品者的人数。
BMC Public Health. 2017 Sep 29;17(1):757. doi: 10.1186/s12889-017-4785-7.
4
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review.注射吸毒人群中注射吸毒与艾滋病毒的全球流行病学:一项系统评价。
Lancet. 2008 Nov 15;372(9651):1733-45. doi: 10.1016/S0140-6736(08)61311-2. Epub 2008 Sep 23.
5
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.注射吸毒的流行病学、与注射相关的危害的流行率,以及注射吸毒者的行为和环境风险的暴露情况:系统评价。
Lancet Glob Health. 2023 May;11(5):e659-e672. doi: 10.1016/S2214-109X(23)00057-8. Epub 2023 Mar 27.
6
Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis.国家发展指标与注射吸毒者年龄分布的关联:全球系统评价和荟萃分析的结果。
Lancet Glob Health. 2020 Jan;8(1):e76-e91. doi: 10.1016/S2214-109X(19)30462-0.
7
Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis.在东地中海地区注射吸毒者中注射吸毒、艾滋病毒、乙型肝炎和丙型肝炎的流行情况:系统评价和荟萃分析。
Lancet Glob Health. 2023 Aug;11(8):e1225-e1237. doi: 10.1016/S2214-109X(23)00267-X.
8
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis.注射吸毒者中丙型肝炎病毒(HCV)感染发病率以及每年因注射吸毒导致的新增HCV感染病例数的全球、区域和国家估计:一项多阶段分析
Lancet Gastroenterol Hepatol. 2025 Apr;10(4):315-331. doi: 10.1016/S2468-1253(24)00442-4. Epub 2025 Feb 21.
9
Patterns of drug use among people who inject drugs: A global systematic review and meta-analysis.注射吸毒者的吸毒模式:一项全球系统评价和荟萃分析。
Int J Drug Policy. 2024 Jun;128:104455. doi: 10.1016/j.drugpo.2024.104455. Epub 2024 May 25.
10
Does sexuality matter? A cross-sectional study of drug use, social injecting, and access to injection-specific care among men who inject drugs in Melbourne, Australia.性行为重要吗?在澳大利亚墨尔本,对注射吸毒者进行的一项横断面研究,评估了他们的药物使用、社交性注射和获得注射特定护理的情况。
Harm Reduct J. 2023 Jan 23;20(1):9. doi: 10.1186/s12954-023-00737-6.

引用本文的文献

1
Invited commentary: motivating better methods-and better data collection-for measuring the prevalence of drug misuse.特邀评论:激发采用更好的方法和更好的数据收集方式来衡量药物滥用的患病率。
Am J Epidemiol. 2025 Jan 8;194(1):12-16. doi: 10.1093/aje/kwae156.
2
Long-acting Injectable PrEP Interest and General PrEP Awareness among People who Inject Drugs in the San Diego-Tijuana Border Metroplex.在圣地亚哥-蒂华纳边境都会区,注射吸毒者对长效注射型 HIV 预防药物的兴趣和对一般 HIV 预防药物的认识。
AIDS Behav. 2024 May;28(5):1650-1661. doi: 10.1007/s10461-024-04285-3. Epub 2024 Feb 6.
3
Impact of the Russian invasion on opioid agonist therapy programs in Ukraine: A qualitative study.俄罗斯入侵对乌克兰阿片类激动剂治疗项目的影响:一项定性研究。
Drug Alcohol Depend. 2024 Feb 1;255:111069. doi: 10.1016/j.drugalcdep.2023.111069. Epub 2023 Dec 26.
4
Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis.注射吸毒人群中慢性乙型肝炎患病率与国家层面特征的相关性:生态分析。
Drug Alcohol Rev. 2023 Mar;42(3):569-581. doi: 10.1111/dar.13595. Epub 2023 Jan 4.
5
Estimating the prevalence of problem drug use from drug-related mortality data.从与毒品相关的死亡率数据估算药物滥用的流行率。
Addiction. 2020 Dec;115(12):2393-2404. doi: 10.1111/add.15111. Epub 2020 Jun 9.
6
Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine.带药纳洛酮:急诊医学在阿片类药物过量急救管理中的公共卫生应用
Drugs. 2019 Sep;79(13):1395-1418. doi: 10.1007/s40265-019-01154-5.

本文引用的文献

1
Commentary on Lai et al. (2018): Potential and limitations of wastewater-based epidemiology in monitoring substance use.关于赖等人(2018年)的评论:基于废水的流行病学在监测物质使用方面的潜力和局限性
Addiction. 2018 Jun;113(6):1137-1138. doi: 10.1111/add.14207.
2
Measuring spatial and temporal trends of nicotine and alcohol consumption in Australia using wastewater-based epidemiology.利用基于污水的流行病学方法测量澳大利亚尼古丁和酒精消费的时空趋势。
Addiction. 2018 Jun;113(6):1127-1136. doi: 10.1111/add.14157. Epub 2018 Feb 26.
3
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.全球注射吸毒流行状况以及注射吸毒者的社会人口学特征和艾滋病毒、乙肝病毒及丙肝病毒流行状况:多阶段系统评价。
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23.
4
Estimating the number of people who inject drugs in Australia.估算澳大利亚注射毒品者的人数。
BMC Public Health. 2017 Sep 29;17(1):757. doi: 10.1186/s12889-017-4785-7.
5
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.2015 年全球丙型肝炎病毒感染的流行率和基因型分布:一项建模研究。
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176. doi: 10.1016/S2468-1253(16)30181-9. Epub 2016 Dec 16.
6
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.估算因注射吸毒作为 HIV、丙型肝炎和乙型肝炎的风险因素而导致的疾病负担:来自 2013 年全球疾病负担研究的结果。
Lancet Infect Dis. 2016 Dec;16(12):1385-1398. doi: 10.1016/S1473-3099(16)30325-5. Epub 2016 Sep 21.
7
Recapture or precapture? Fallibility of standard capture-recapture methods in the presence of referrals between sources.再捕获还是预捕获?在来源之间存在转介的情况下,标准捕获-再捕获方法的易错性。
Am J Epidemiol. 2014 Jun 1;179(11):1383-93. doi: 10.1093/aje/kwu056. Epub 2014 Apr 11.
8
Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007.1992-2007 年美国大都市地区注射吸毒人群的流行趋势。
PLoS One. 2013 Jun 5;8(6):e64789. doi: 10.1371/journal.pone.0064789. Print 2013.
9
Multiple parameter evidence synthesis--a potential solution for when information on drug use and harm is in conflict.多参数证据综合——当药物使用和危害信息存在冲突时的一种潜在解决方案。
Addiction. 2013 Sep;108(9):1529-31. doi: 10.1111/add.12185. Epub 2013 Apr 22.
10
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.21 个地区 1990-2010 年 67 种致病因素和致病因素群导致的疾病和伤害负担的比较风险评估:全球疾病负担研究 2010 系统分析。
Lancet. 2012 Dec 15;380(9859):2224-60. doi: 10.1016/S0140-6736(12)61766-8.

全球关于注射吸毒流行率的竞争统计数据:为什么这很重要,我们能做些什么?

Competing global statistics on prevalence of injecting drug use: why does it matter and what can be done?

机构信息

University of Bristol, Bristol, UK.

University of New South Wales, Sydney, Australia.

出版信息

Addiction. 2018 Oct;113(10):1768-1774. doi: 10.1111/add.14383. Epub 2018 Aug 9.

DOI:10.1111/add.14383
PMID:29989282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6717512/
Abstract

Variation in global estimates of the prevalence of injecting or opioid use from recent reports are partly explained by use of alternative information sources and value given to unreferenced country estimates; but also highlights a prevailing problem with the reporting and robustness of prevalence estimates. Unfortunately, there is no quick solution: we need investment both in ongoing information or surveillance of drug related harms and clinical and other interventions and in the implementation of more refined statistical methods to estimate prevalence.

摘要

全球最近报告中关于注射或阿片类药物使用流行率的估计值存在差异,部分原因是使用了替代信息来源和对未引用国家估计值的重视;但这也突出了报告和流行率估计值的稳健性方面存在的一个普遍问题。不幸的是,目前没有快速的解决方案:我们需要在药物相关危害的持续信息或监测、临床和其他干预措施以及更精细的统计方法实施方面进行投资,以估计流行率。